TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in TScan Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- +12 vs. Q4 2023
- Shares held
- 34.3M
- +2.38M (+7.5%) vs. Q4 2023
- Total value
- $272.3M
- +$86.3M (+46.4%) vs. Q4 2023
- New holders
- 17
- 22 more added
- Sold out
- 5
- 9 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 5,224,600 | $41.5M | 10.68% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 5,000,000 | $39.7M | 1.01% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 3,900,000 | $31.0M | 0.06% | 00.0% | Unchanged |
| BVF Inc | 2,989,474 | $23.7M | 0.65% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,784,792 | $22.1M | 0.28% | 00.0% | Unchanged |
| Propel Bio Management, LLC | 2,087,139 | $16.6M | 9.65% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,808,152 | $14.4M | 0.00% | +20,000+1.1% | Added |
| BlackRock Inc. | 1,699,213 | $13.5M | 0.00% | +27,486+1.6% | Added |
| Deer Management Co. LLC | 1,245,504 | $9.89M | 1.79% | −10.0% | Reduced |
| Alphabet Inc. | 1,077,080 | $8.55M | 0.34% | 00.0% | Unchanged |
| Simplify Asset Management Inc. | 1,046,916 | $8.31M | 0.80% | 00.0% | Unchanged |
| DC Funds, LP | 630,000 | $5.00M | 48.34% | 00.0% | Unchanged |
| Invesco Ltd. | 488,415 | $3.88M | 0.00% | +488,415 | New |
| Geode Capital Management, LLC | 413,779 | $3.29M | 0.00% | +22,133+5.7% | Added |
| Millennium Management LLC | 392,115 | $3.11M | 0.00% | +293,033+295.7% | Added |
| Laurion Capital Management LP | 362,484 | $2.88M | 0.08% | +302,084+500.1% | Added |
| Susquehanna International Group, LLP | 297,902 | $2.37M | 0.00% | +193,954+186.6% | Added |
| Goldman Sachs Group Inc | 260,148 | $2.07M | 0.00% | +229,863+759.0% | Added |
| Morgan Stanley | 223,894 | $1.78M | 0.00% | −10,809−4.6% | Reduced |
| Tocqueville Asset Management L.P. | 212,200 | $1.68M | 0.03% | +212,200 | New |
| Standard Life Aberdeen plc | 200,000 | $1.59M | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 191,171 | $1.52M | 0.00% | +80,620+72.9% | Added |
| Jane Street Group, LLC | 153,133 | $1.22M | 0.00% | +69,511+83.1% | Added |
| Qube Research & Technologies Ltd | 143,536 | $1.14M | 0.00% | +63,547+79.4% | Added |
| State Street Corp | 135,000 | $1.07M | 0.00% | +73,900+120.9% | Added |
| Citigroup Inc | 116,921 | $928.4K | 0.00% | +43,758+59.8% | Added |
| Stifel Financial Corp | 101,400 | $805.1K | 0.00% | −19,000−15.8% | Reduced |
| NewEdge Wealth, LLC | 91,463 | $791.2K | 0.02% | 00.0% | Unchanged |
| Man Group plc | 77,339 | $614.1K | 0.00% | +26,929+53.4% | Added |
| Northern Trust Corp | 76,960 | $611.1K | 0.00% | +5,349+7.5% | Added |
| JPMorgan Chase & Co | 67,013 | $532.1K | 0.00% | +33,783+101.7% | Added |
| Bridgeway Capital Management, LLC | 63,300 | $502.6K | 0.01% | −25,000−28.3% | Reduced |
| Walleye Capital LLC | 52,478 | $416.7K | 0.00% | +34,701+195.2% | Added |
| Marathon Trading Investment Management LLC | 51,000 | $404.9K | 0.16% | +51,000 | New |
| Renaissance Technologies LLC | 47,000 | $373.0K | 0.00% | +25,300+116.6% | Added |
| Cubist Systematic Strategies, LLC | 44,308 | $351.8K | 0.00% | +18,063+68.8% | Added |
| Balyasny Asset Management LLC | 41,942 | $333.0K | 0.00% | −4,044−8.8% | Reduced |
| Two Sigma Investments, LP | 37,747 | $299.7K | 0.00% | +37,747 | New |
| ExodusPoint Capital Management, LP | 35,661 | $283.0K | 0.00% | −28,117−44.1% | Reduced |
| DC Investments Management, LLC | 35,563 | $282.4K | 0.24% | 00.0% | Unchanged |
| HRT Financial LP | 34,789 | $276.0K | 0.00% | +34,789 | New |
| Brevan Howard Capital Management LP | 34,578 | $274.5K | 0.02% | +34,578 | New |
| American Century Companies Inc | 31,885 | $253.2K | 0.00% | +10,570+49.6% | Added |
| Bank of America Corp | 30,179 | $239.6K | 0.00% | −7,625−20.2% | Reduced |
| Y-Intercept (Hong Kong) Ltd | 24,446 | $194.1K | 0.01% | +9,441+62.9% | Added |
| Charles Schwab Investment Management Inc | 22,104 | $175.5K | 0.00% | 00.0% | Unchanged |
| Pale Fire Capital SE | 21,573 | $171.3K | 0.02% | 00.0% | Unchanged |
| Letko, Brosseau & Associates Inc | 20,700 | $164.4K | 0.00% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 19,736 | $156.7K | 0.04% | +19,736 | New |
| Cannon Global Investment Management, LLC | 17,500 | $138.9K | 0.37% | +17,500 | New |
| Credit Suisse AG | 17,366 | $137.9K | 0.00% | +17,366 | New |
| Privium Fund Management (UK) Ltd | 15,825 | $126.8K | 0.06% | 00.0% | Unchanged |
| Omers Administration Corp | 14,200 | $112.7K | 0.00% | +14,200 | New |
| Jefferies Financial Group Inc. | 12,200 | $96.9K | 0.00% | +12,200 | New |
| Citadel Advisors LLC | 11,432 | $90.8K | 0.00% | +11,432 | New |
| CTC Alternative Strategies, Ltd. | 11,000 | $87.3K | 0.05% | +11,000 | New |
| Jump Financial, LLC | 10,291 | $81.7K | 0.00% | +10,291 | New |
| Cambridge Investment Research Advisors, Inc. | 10,061 | $80.0K | 0.00% | +10,061 | New |
| Waldron Private Wealth LLC | 10,000 | $79.4K | 0.00% | 00.0% | Unchanged |
| Aries Wealth Management | 10,000 | $79.4K | 0.03% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 2,551 | $19.0K | 0.00% | −1,432−36.0% | Reduced |
| UBS Group AG | 1,901 | $15.1K | 0.00% | +477+33.5% | Added |
| Wells Fargo & Company | 306 | $2.43K | 0.00% | +5+1.7% | Added |
| Federated Hermes, Inc. | 56 | $445 | 0.00% | +56 | New |
| Atlas Capital Advisors LLC | 18 | $142 | 0.00% | −878−98.0% | Reduced |
| Macquarie Group Ltd | 1,618 | $13 | 0.00% | +1,618 | New |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −43,198−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −18,418−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −16,670−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −13,293−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −43−100.0% | Sold out |